Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4397 followers
Created: 2025-06-12 10:30:12 UTC

$APLT Appointments:

On June 9, 2025, Applied Therapeutics, Inc. held its Annual Meeting where stockholders elected a new director, ratified Ernst & Young as auditors, approved executive compensation, chose to hold future votes annually, and approved a stock consolidation plan ranging from 1-for-5 to 1-for-40. The meeting reflected active shareholder engagement and governance decisions.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1933109574367690883/c:line.svg)

**Related Topics**
[governance](/topic/governance)
[$aplt](/topic/$aplt)
[sec](/topic/sec)

[Post Link](https://x.com/USCorpFilings/status/1933109574367690883)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

USCorpFilings Avatar SEC Filings Digest @USCorpFilings on x 4397 followers Created: 2025-06-12 10:30:12 UTC

$APLT Appointments:

On June 9, 2025, Applied Therapeutics, Inc. held its Annual Meeting where stockholders elected a new director, ratified Ernst & Young as auditors, approved executive compensation, chose to hold future votes annually, and approved a stock consolidation plan ranging from 1-for-5 to 1-for-40. The meeting reflected active shareholder engagement and governance decisions.

XXX engagements

Engagements Line Chart

Related Topics governance $aplt sec

Post Link

post/tweet::1933109574367690883
/post/tweet::1933109574367690883